Confident Investing Starts With TipRanks Premium

Go Ultimate 55% OFF

HK:9688 Stock Latest News

Company AnnouncementsZai Lab Raises US$250 Million in ADS Private Placement to Fund Oncology Pipeline4d ago

Company AnnouncementsZai Lab Sets November 5 Date to Approve and Reveal Q3 2026 Results1w ago
Company AnnouncementsZai Lab’s Lung Cancer ADC Zoci Delivers Strong Early Efficacy Ahead of Global Phase 31w ago
The FlyZai Lab reports results from Phase 1b trial of zocilurtatug pelitecan1w agoZLAB
Company AnnouncementsZai Lab Details Private Placement in U.S. Form 8-K Filing1w ago

Zai Lab announces $250M private placement

The FlyZai Lab announces $250M private placement1w agoZLAB

Company AnnouncementsZai Lab Raises Capital via US$22.04 ADS Private Placement1w ago

Company AnnouncementsZai Lab Formalizes Nominating and Governance Committee Charter1w ago

The FlyZai Lab management to meet with Cantor2w agoZLAB
Company AnnouncementsZai Lab Grants New Restricted Share Units Under 2024 Equity Incentive Plan1M ago
The FlyZai Lab price target raised to $36 from $27 at JPMorgan2M agoZLAB
Company AnnouncementsZai Lab’s Interim Results Show Lower Revenue but Rising R&D Investment2M ago

Zai Lab and Argenx announce results from Alkivia Phase 3 study

The FlyZai Lab and Argenx announce results from Alkivia Phase 3 study2M agoARGX ZLAB

Company AnnouncementsZai Lab to Align Hong Kong Interim Results With Previously Filed U.S. Financials2M ago

Company AnnouncementsZai Lab Grants New Employee Share Options and Restricted Units Under 2024 Plan2M ago

The FlyZai Lab price target raised to $45 from $44 at Citi2M agoZLAB
Company AnnouncementsZai Lab’s Q2 Revenue Climbs as Oncology and Immunology Pipeline Nears Key Milestones2M ago
Company AnnouncementsZai Lab Files Latest Quarterly Report with U.S. Regulator2M ago
The FlyZai Lab reports Q2 EPS (46c), consensus (68c)2M agoZLAB

Zai Lab says FDA grants Orphan Drug Designation for zocilurtatug pelitecan

The FlyZai Lab says FDA grants Orphan Drug Designation for zocilurtatug pelitecan3M agoZLAB

The FlyZai Lab treatment of neuroendocrine carcinoma granted FDA orphan designation3M agoZLAB

Company AnnouncementsZai Lab Sets August 6 Date to Approve and Publish 2026 Interim Results3M ago